The London Company, an investment management company, released “The London Company Mid Cap Strategy” third quarter 2024 ...

Citi analyst Atif Malik maintained a Buy rating on Entegris (ENTG – Research Report) today and set a price target of $123.00. The ...

Entegris (ENTG – Research Report), the Technology sector company, was revisited by a Wall Street analyst today. Analyst Charles Shi from ...

周二，KeyBanc Capital Markets调整了Entegris Inc (NASDAQ:ENTG)的目标价，该公司是微电子行业特种化学品和先进材料解决方案的领先供应商。该公司将股票目标价从164美元下调至154美元，同时保持增持评级。

周二，BMO Capital Markets调整了对半导体材料市场关键参与者Entegris Inc (NASDAQ:ENTG)的展望。分析师Bhavesh Lodaya将公司的目标价从之前的$145下调至$135，同时维持对该股票的"优于大市"评级。

Revenue missed analyst estimates by 3.0%. Earnings per share (EPS) exceeded analyst estimates by 8.3%. Looking ahead, revenue ...

Welcome to the Entegris' third quarter 2024 earnings conference call. (Operator Instructions). I would now like to turn the call over to Bill Seymour, Vice President of Investor Relations.

Entegris shares are moving lower on Monday after the company reported worse-than-expected 2024 third-quarter financial ...

Semiconductor materials supplier Entegris (NASDAQ:ENTG) missed Wall Street’s revenue expectations in Q3 CY2024, with sales ...

Alexander's Inc (ALX) is expected to report for 3Q. Algoma Central Corp (ALC.T) is expected to report for 3Q. BioCryst Pharmaceuticals Inc (BCRX) is expected to report $-0.07 for 3Q.

Entegris, Inc. reported a 9% decrease in net sales for the third quarter of 2024, with adjusted sales showing a 7% year-over-year increase.